agentes para o tratamento da artrite gotosa, uma vez que possui ambas as propriedades. anti-hiperuricêmica e anti-inflamatória. O extrato etanólico bruto e. Revisão crítica do tratamento medicamentoso da gota no Brasil tratamento da hiperuricemia e da artrite gotosa e especialmente para. Os objetivos principais do tratamento da tuberculose são curar o paciente e .. Artrite gotosa aguda: É rara, exceto em pacientes que apresentam história.
|Published (Last):||3 November 2014|
|PDF File Size:||20.54 Mb|
|ePub File Size:||17.36 Mb|
|Price:||Free* [*Free Regsitration Required]|
Podem ser tratadas conforme o descrito para a isoniazida. Alertar o paciente quanto a esta possibilidade. Pode provocar manchas em lentes de contato. Pode ser devido ao uso de rifampicina ou ter sido produzido por outro medicamento associado.
A CIM para o M. A nova diretriz para o tratamento da tuberculose no Brasil 1,2 preconiza a dose de 1. A OMS considera o seu uso seguro. A OMS o considera uma droga segura na gravidez. Pode ser usada em doses plenas. Associada a gotoda, pode levar a uma hepatite medicamentosa aguda e fulminante, felizmente rara. Solicitar, nesses casos, dosagem das aminotransferases, fosfatase alcalina botosa bilirrubinas. Programa Nacional de Controle da Tuberculose. Guidelines for National Programmes.
World Health Organization; Med Clin North Am. Risk factors for sideeffects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis. Adverse reactions of antituberculosis drugs in hospitalized artfite Incidence of serious side effects from firstline antituberculosis drugs among patients treated for active tuberculosis.
Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infection. Int J Tuberc Lung Dis. Evaluation of anti-tuberculosis induced adverse reactions in hospitalized patients.
Vieira DE, Gomes M. Adverse effects of tuberculosis treatment: The magic bullets and tuberculosis drug targets.
Annu Rev Pharmacol Toxicol. Handbook of Anti-Tuberculosis Agents. The genetics and biochemistry of isoniazid resistance in mycobacterium tuberculosis. Role of reactive metabolites in drug-induced hepatotoxicity. Incidence, clinical and epidemiological risk factors, and outcome of drug-induced hepatitis due to antituberculous agents in new tuberculosis cases. The use of potentially hepatotoxic drugs in patients with liver disease. The role of chronic hepatitis in isoniazid hepatotoxicity during treatment for latent tuberculosis infection.
Tratamentl isoniazidassociated deaths in one state. Am Rev Respir Dis. British Infection Tratamehto guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. Tajender V, Saluja J. INH induced status epilepticus: Coma caused by isoniazid poisoning in a patient treated with pyridoxine and hemodialysis.
Forget EJ, Menzies D. Adverse reactions to firstline antituberculosis drugs. Expert Opin Drug Saf. Exacerbation of isoniazid induced peripheral neuropathy by pyridoxine. Severe systemic lupus erythematosus induced by isoniazid [Article in French]. Risks of antibacterial agents in pregnancy [Article in Italian].
American Academy of Pediatrics Committee on Drugs.
There was a problem providing the content you requested
Transfer of drugs and other chemicals trattamento human milk. A prospective study of hepatitis during antituberculous treatment in Taiwanese patients and a review of the literature.
J Formos Med Assoc. Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy. Inhibition of cytochrome P CYP isoforms by isoniazid: Isoniazid-induced hyperacute liver failure in a young patient receiving carbamazepine.
Eur J Intern Med. Isoniazid drug and food interactions. Am J Med Sci. Ramaswamy S, Musser JM.
Moreira Jr Editora | RBM Revista Brasileira de Medicina
Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. Haemorrhage associated with vitamin K deficiency in pregnant women and newborns.
Relationship with rifampicin therapy in two cases [Article in French]. Update on rifampin and rifabutin drug interactions. Pharmacokinetic interactions with rifampicin: Tuberculosis and diabetes mellitus: Dose adjustment of the non-nucleoside reverse transcriptase inhibitors during concurrent rifampicin-containing tuberculosis therapy: Expert Opin Drug Metab Toxicol.
Clinically significant interactions with drugs used in the treatment of tuberculosis. Interaction of ketoconazole artritte rifampin and isoniazid. N Engl J Med. Chemotherapy and management of tuberculosis in the United Kingdom: Zhang Y, Yew WW.
Mechanisms of drug resistance in Mycobacterium tuberculosis. Gotsoa Treatment of Tuberculosis Guidelines. The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis. Ocular toxicity from ethambutol.
Ocular toxicity of ethambutol. Hong Kong Med J. The effect of hemodialysis on isoniazid, rifampin, pyrazinamide, and ethambutol. Multidrug-resistant and extensively drug-resistant tuberculosis in the West.
Europe and United States: An official ATS statement: Antituberculosis drugs and hepatotoxicity. Srtrite hepatotoxicity due to anti-tuberculosis drugs in Spain. Treatment of tuberculosis in presence of hepatic and renal impairment. All the contents of this journal, except where otherwise noted, tratamennto licensed under a Creative Commons Attribution License.
Services on Demand Journal. SCS Quadra 1, Bl. How to cite this article.